O’Carrigan, Brent
Lim, Joline Si Jing
Jalil, Awais
Harris, Samuel John
Papadatos-Pastos, Dionysis
Banerji, Udai
Lopez, Juanita
de Bono, Johann Sebastian
Yap, Timothy Anthony
Article History
Received: 15 May 2018
Revised: 7 September 2018
Accepted: 17 September 2018
First Online: 15 October 2018
Competing interests
: The authors declare no competing interests.
: All study protocols, including therapeutic trials and the molecular characterisation protocol, were approved by the Royal Marsden Hospital Research Ethics Committee (REC). REC reference numbers for each participating study can be provided upon request. All study participants provided written informed consent both to molecular characterisation and individual therapeutic trials. The study was conducted in accordance with the Declaration of Helsinki.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).